SCHEMBL357139

SCHEMBL357139

CCCC[n+]1ccn(C)c1.O=S(=O)([O-])C(F)(F)C(F)F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
MAPT P10636 4/20 0.34
HTT P42858 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
APAF1 O14727 3/20 0.32
KMT2A Q03164 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
LMNA P02545 1/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
KDM4E B2RXH2 4/20 0.32
ACHE P22303 1/20 0.32
RXFP1 Q9HBX9 2/20 0.31
MEN1 O00255 1/20 0.31
MITF O75030 1/20 0.31
BLM P54132 1/20 0.31
PABPC1 P11940 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1736109 0.95 MEN1 (0.34) ALDH1A1MAPTHTTAPAF1KMT2A
SCHEMBL1735066 0.95 MEN1 (0.34) ALDH1A1MAPTHTTAPAF1KMT2A
SCHEMBL1858365 0.95 MEN1 (0.34) ALDH1A1MAPTHTTAPAF1KMT2A
SCHEMBL358007 0.95 MEN1 (0.34) ALDH1A1MAPTHTTAPAF1KMT2A
SCHEMBL1735956 0.95 MEN1 (0.34) ALDH1A1MAPTHTTAPAF1KMT2A
SCHEMBL1736114 0.95 MEN1 (0.34) ALDH1A1MAPTHTTAPAF1KMT2A
Hydrochloric Acid SCHEMBL3648005 0.94 MEN1 (0.34) ALDH1A1MAPTHTTSMN1; SMN2APAF1
Hydrochloric Acid SCHEMBL3648019 0.94 MEN1 (0.34) ALDH1A1MAPTHTTSMN1; SMN2APAF1
Hydrochloric Acid SCHEMBL3645838 0.94 MEN1 (0.34) ALDH1A1MAPTHTTSMN1; SMN2APAF1
Hydrochloric Acid SCHEMBL3647822 0.94 MEN1 (0.34) ALDH1A1MAPTHTTSMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2021276-B1 PROCESS FOR PURIFYING PERFLUORINATED PRODUCTS DU PONT (US) 2013-07-17 EP claimed
EP-1954680-B1 IONIC LIQUIDS DU PONT (US) 2012-05-23 EP claimed
US-20120011886-A1 IONIC COMPOUNDS IN LITHIUM BROMIDE/WATER ABSORPTION CYCLE SYSTEMS E. I. DU PONT DE NEMOURS AND COMPANY 2012-01-19 US claimed
US-20200129922-A1 METHOD OF REDUCING CONCENTRATION OF FLUORINE-CONTAINING COMPOUND IN SAMPLE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 US disclosed
EP-3080859-B1 NA BASED SECONDARY BATTERY FIELD UPGRADING USA (US) 2020-04-08 EP disclosed
CN-104617338-B Sodium rechargeable battery comprising forming slotted graphite felt SK新技术株式会社 2019-11-12 CN disclosed
CN-104600352-B Sodium rechargeable battery with the graphite felt for forming air vent channel SK INNOVATION CO.,LTD. (KR) 2019-11-01 CN disclosed
US-10367226-B2 Na based secondary battery SK INNOVATION CO., LTD. (KR) 2019-07-30 US disclosed
US-9780380-B2 Current collector for battery and secondary battery comprising the same SK INNOVATION CO., LTD. (KR) 2017-10-03 US disclosed
US-9755270-B2 Sodium secondary battery including graphite felt having pore channels formed therein SK INNOVATION CO., LTD. (KR) 2017-09-05 US disclosed
US-9608274-B2 Sodium secondary battery including graphite felt as current collector SK INNOVATION CO., LTD. (KR) 2017-03-28 US disclosed
US-20070131535-A1 Utilizing ionic liquids for hydrofluorocarbon separation THE CHEMOURS COMPANY FC, LLC 2007-06-14 US disclosed
US-20070100184-A1 Alkylation of aromatic compounds E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed
WO-2007050492-A1 ALKYLATION OF AROMATIC COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-05-03 WO disclosed
US-20070066854-A1 Preparation of polytrimethylene ether glycol and copolymers thereof THE CHEMOURS COMPANY FC, LLC 2007-03-22 US disclosed
US-20070066852-A1 Preparation of poly(tetramethylene) glycol THE CHEMOURS COMPANY FC, LLC 2007-03-22 US disclosed
US-20070066822-A1 Ionic liquids THE CHEMOURS COMPANY FC, LLC 2007-03-22 US disclosed
US-20070019708-A1 Hybrid vapor compression-absorption cycle E. I. DU PONT DE NEMOURS AND COMPANY 2007-01-25 US disclosed
US-20060197053-A1 Absorption cycle utilizing ionic liquid as working fluid E. I. DU PONT DE NEMOURS AND COMPANY 2006-09-07 US disclosed
WO-2006084262-A1 ABSORPTION CYCLE UTILIZING IONIC LIQUID AS WORKING FLUID E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100184-A1 Alkylation of aromatic compounds TYR, ALK, AHR ALDH1A1 543/4885MAPT 798/4885HTT 900/4885
US-20070066854-A1 Preparation of polytrimethylene ether glycol and copolymers thereof PARG, PTGES3, PGD ALDH1A1 840/4885MAPT 2208/4885HTT 4120/4885
US-20070131535-A1 Utilizing ionic liquids for hydrofluorocarbon separation AQP3, AQP1, SLC26A3 ALDH1A1 1317/4885MAPT 1618/4885HTT 18/4885
US-20070066822-A1 Ionic liquids AFF2, AFF1, ZYX ALDH1A1 3728/4885MAPT 3942/4885HTT 4577/4885
US-20070066852-A1 Preparation of poly(tetramethylene) glycol PARG, PUF60, TPR ALDH1A1 2896/4885MAPT 296/4885HTT 199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.